Melexis NV (Belgium) Earnings Calls
| Release date | Jul 29, 2026 |
| EPS estimate | $0.82 |
| EPS actual | $0.87 |
| EPS Surprise | 6.50% |
| Revenue estimate | 240.104M |
| Revenue actual | 247.86M |
| Revenue Surprise | 3.23% |
| Release date | Apr 29, 2026 |
| EPS estimate | $0.704 |
| EPS actual | $0.659 |
| EPS Surprise | -6.39% |
| Revenue estimate | 233.784M |
| Revenue actual | 233.493M |
| Revenue Surprise | -0.124% |
| Release date | Feb 04, 2026 |
| EPS estimate | $0.798 |
| EPS actual | $0.658 |
| EPS Surprise | -17.54% |
| Revenue estimate | 254.717M |
| Revenue actual | 251.924M |
| Revenue Surprise | -1.10% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.83 |
| EPS actual | $0.81 |
| EPS Surprise | -1.94% |
| Revenue estimate | 216.783M |
| Revenue actual | 252.627M |
| Revenue Surprise | 16.53% |
Last 4 Quarters for Melexis NV (Belgium)
Below you can see how MLXSF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 29, 2025 |
| Price on release | $77.00 |
| EPS estimate | $0.83 |
| EPS actual | $0.81 |
| EPS surprise | -1.94% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $77.00 |
| Oct 24, 2025 | $88.28 |
| Oct 27, 2025 | $77.00 |
| Oct 28, 2025 | $77.00 |
| Oct 29, 2025 | $77.00 |
| Oct 30, 2025 | $77.00 |
| Oct 31, 2025 | $88.28 |
| Nov 03, 2025 | $77.00 |
| Nov 04, 2025 | $77.00 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 04, 2026 |
| Price on release | $65.62 |
| EPS estimate | $0.798 |
| EPS actual | $0.658 |
| EPS surprise | -17.54% |
| Date | Price |
|---|---|
| Jan 29, 2026 | $70.15 |
| Jan 30, 2026 | $65.62 |
| Feb 02, 2026 | $65.62 |
| Feb 03, 2026 | $65.62 |
| Feb 04, 2026 | $65.62 |
| Feb 05, 2026 | $65.62 |
| Feb 06, 2026 | $65.62 |
| Feb 09, 2026 | $65.62 |
| Feb 10, 2026 | $65.62 |
| 4 days before | -6.46% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -6.46% |
| Release date | Apr 29, 2026 |
| Price on release | $76.00 |
| EPS estimate | $0.704 |
| EPS actual | $0.659 |
| EPS surprise | -6.39% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $76.00 |
| Apr 24, 2026 | $70.15 |
| Apr 27, 2026 | $76.00 |
| Apr 28, 2026 | $76.00 |
| Apr 29, 2026 | $76.00 |
| Apr 30, 2026 | $76.00 |
| May 01, 2026 | $76.00 |
| May 04, 2026 | $76.00 |
| May 05, 2026 | $76.00 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Jul 29, 2026 |
| Price on release | $76.00 |
| EPS estimate | $0.82 |
| EPS actual | $0.87 |
| EPS surprise | 6.50% |
| Date | Price |
|---|---|
| Jul 23, 2026 | $76.00 |
| Jul 24, 2026 | $76.00 |
| Jul 27, 2026 | $76.00 |
| Jul 28, 2026 | $76.00 |
| Jul 29, 2026 | $76.00 |
| Jul 30, 2026 | $76.00 |
| Jul 31, 2026 | $76.00 |
| Aug 03, 2026 | $76.00 |
| Aug 04, 2026 | $76.00 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Melexis NV (Belgium) Earnings Call Transcript Summary of Q2 2026
Melexis reported Q2 2026 sales of EUR 217.3m (up 3% YoY, 7% QoQ) with gross margin at 40.5% and operating margin at 17.8%. Net income was EUR 30.8m (EUR 0.76/sh), down 19% YoY but up 33% QoQ. The Board declared an interim dividend of EUR 1.30 gross per share. Management highlighted stronger order momentum through the quarter, particularly in position sensors (automotive steering/braking and robotic joints), motor drivers (thermal management and robotics), and traction for new power-electronic solutions (snubber, digital current sensors). Melexis launched three new Q2 products (lighting chip with DC-DC, a 4-position contactless switch, and a digital current sensor). China showed particularly strong growth driven by local customers; Q3 China activity is expected to be even higher. Inventory was reduced versus year-end partly due to consumption and revaluation; management expects to rebuild inventory later in the year. Pricing: Melexis has not implemented broad price increases in 2026 and is prioritizing volume/long-term customer relationships while negotiations continue. Outlook: Q3 sales guidance EUR 220–225m; H2 sales EUR 445–455m with gross margin around 41% and operating margin around 18% (assumes EUR/USD 1.15). FY2026 CapEx expected around EUR 40m. Management reiterated continued R&D investment, footprint shifts toward China (assembly & test today; wafer localization ramping later), and ongoing work on cost-of-yield and margin roadmap toward longer-term gross margin targets (~45%). Key investor takeaways: modest but improving top-line momentum with margin expansion QoQ, constructive product/market diversification (automotive + robotics + data center/thermal), disciplined pricing stance favoring volume, and clear China strategy—but visibility remains short (4–5 months) and management expects wage inflation and other cost pressures to moderate operating leverage near term.
Sign In
Buy MLXSF